close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
3 mins to read

Infant formula maker Bellamy's shares plunge on profit warning, CEO exit

Changes terms of its supply contract with Fonterra.

Rebecca Howard
Thu, 12 Jan 2017

Bellamy's Australia shares took a nose dive after it cut its profit forecast for a second time, announced chief executive Laura McBain is leaving the company, and tweaked the terms of its supply contract with Fonterra Cooperative Group.

The ASX-listed shares, which have been on a trading halt since Dec. 12, were trading down 34 percent at A$4.39 after the beleaguered dairy company said lower than expected demand for its baby formula has impacted its revenue and profitability, leading to increased inventory levels, excess ingredients and shortfall payments to suppliers.

The stock had already plunged 40 percent when Bellamy's issued a profit warning last month, citing a temporary hit to sales volumes due to the regulatory changes and changes in the sales channels. The company called a trading halt pending the outcome of talks with key suppliers and manufacturers that could have a bearing on earnings.

Bellamy's has run into trouble after China moved to tighten regulations in a bid to crack down on the grey market and allay concerns about food safety. Under the changes, each legal entity will only be allowed to have three brands with three recipes for infant formula, something that's expected to decimate the number of brands and labels on supermarket shelves in China from more than 2,000 currently to around 200.

On Wednesday, Bellamy's said it now expects FY17 revenue to be in range of A$220 million to A$240 million versus a prior forecast of A$240 million. In the prior year, revenue was A$244.6 million.

It is now tipping FY17 earnings before interest and tax of A$22 million to A$26 million. In the prior year ebit was A$54.3 million. The company also said net profit is expected to be between 6 percent and 9 percent of revenue in the first half and between 4 percent and 6 percent in the second half.

The Launceston, Australia-based company said McBain will cease to be CEO effective today but will continue to be employed until March 31 to assist with outstanding matters. Chief operating officer Andrew Cohen will assume her responsibilities as acting CEO. Nigel Underwood has been appointed acting chief financial officer while the former CFO, Shona Ollington will remain on the finance team and report to Underwood.

During the trading halt, its biggest shareholder Black Prince Private Foundation sought to dump the bulk of the infant formula maker's board. Singapore-based Black Prince, which owns 14.48 percent of Bellamy's, has called a special meeting of shareholders where it wants to remove Patria Mann, Launa Inman, Michael Wadley and Charles Sitch from the board, replacing them with Jan Cameron, Chan Wai-Chan, Vaughan Webber and its authorised representative Rodd Peters.

Bellamy's also announced changes to the take-or-pay organic powder contract between the company and New Zealand's Fonterra.

In late 2015 Fonterra Australia and Bellamy's announced plans to enter into a five-year, multi-million dollar strategic agreement to manufacture a range of new baby nutritional powders at its Darnum plant in Victoria which included the take-or-pay organic powder contract.

At the time, Fonterra touted the deal as being part of the plan to turn around its loss-making Australia business, which has underperformed for several years in an environment of fierce competition for milk supply and over-capacity in dairy production.

Bellamy's today said the term of the contract will be extended by a further three years to "apportion minimum volume commitments over a longer period." The termination rights have also been rejigged with two additional grounds for Fonterra. The first applies if a person or group acquires 50 percent or more of Bellamy's voting shares and the second applies if a person or group acquires more than 40 percent and in Fonterra's opinion that person or group has effective control of Bellamy's.

On an investor and analyst conference call this afternoon, Bellamy's management said they were not able to talk about the Fonterra deal further than what was in the business update. The company said they felt they needed to work with Fonterra but the deal it has with Bega had different metrics and didn't need to be discussed at this point.

Volume commitments to Fonterra have not been cut, the company told investors, but extended over eight years from five years. Management would not discuss whether Bellamy's was liable for a break fee from Fonterra in the event of termination.

Fonterra was not immediately available for comment.

Before the announcement, Forsyth Barr senior analyst equities James Bascand said the situation will be "frustrating" for Fonterra as they are trying to turn around the Australian business but it won't be material.

(BusinessDesk)

Rebecca Howard
Thu, 12 Jan 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Infant formula maker Bellamy's shares plunge on profit warning, CEO exit
64215
false